← FDA Drug Approvals (Drugs@FDA)

ALBENDAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EDENBRIDGE PHARMS · Approved 2019-05-14

Drug application

FDA Application #

ANDA211117

Application type

Abbreviated New Drug Application (Generic)

Brand name

ALBENDAZOLE

Generic name

ALBENDAZOLE

Active ingredients

ALBENDAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EDENBRIDGE PHARMS

Manufacturer

Edenbridge Pharmaceuticals LLC.

First approval

2019-05-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown